Inhibition of stromal cell–induced survival of primary B-CLL cells by cyclopamine in vitro. Inhibition of stromal cell–induced survival of primary B-CLL.

Slides:



Advertisements
Similar presentations
DNA content flow cytometric histograms of propidium iodide–stained A549 cells. DNA content flow cytometric histograms of propidium iodide–stained A549.
Advertisements

KG-501 suppresses NSCLC/IL-1β CM–induced migration of HUVECs by regulating IL-1β–induced CXC chemokine gene expression in NSCLC cells. KG-501 suppresses.
Human Immunodeficiency Virus Type 1 Protease Inhibitor Modulates Activation of Peripheral Blood CD4+ T Cells and Decreases Their Susceptibility to Apoptosis.
Expression of CD10 by Human T Cells That Undergo Apoptosis Both In Vitro and In Vivo by Giovanna Cutrona, Nicolò Leanza, Massimo Ulivi, Giovanni Melioli,
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
by Anupama Narla, Shilpee Dutt, J
Supplementary Fig. 1 Co-treatment inhibited Ki67 expression.
Dihydromyricetin decreases the sphere formation through downregulation of Sox2 in human osteosarcoma. Dihydromyricetin decreases the sphere formation through.
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia by Zachary A. Hing, Rose Mantel,
Suppressive effect of CD39+CD73+ melanoma cells on T-cell proliferation, and reversion of this effect via treatment with the CD39-blocking antibody, CD39.
A B Supplementary Figure 1
Volume 20, Issue 2, Pages (February 2012)
Hematopoietic potential of HEP from patient-specific iPSC may be reduced. Hematopoietic potential of HEP from patient-specific iPSC may be reduced. (A)
Fig. 3. Effects of Tec on IL-1β-induced apoptosis in chondrocytes.
Ectopic expression of caveolin-1 in ZR75 human breast cancer cells downregulated survivin and decreased cell proliferation. Ectopic expression of caveolin-1.
Exosome-mediated inhibition of T cells is reversible.
CYP1A1 knockdown increases cell death.
A, B, apoptosis analysis using Annexin V-FITC/PI was done on 5th, 7th, and 9th day after transfection either with si control or si AEBP1in U87MG and U138MG.
Imatinib mesylate inhibits collagen synthesis in human breast stromal fibroblasts. Imatinib mesylate inhibits collagen synthesis in human breast stromal.
Increased CCL5 expression, infiltration of Treg cells, and apoptosis of CD8+ T cells in human colorectal tissues. Increased CCL5 expression, infiltration.
Stimulatory effect induced by docetaxel, gefitinib, and cyclopamine on MMP (A) and (B) cytosolic cytochrome c level. Stimulatory effect induced by docetaxel,
Reduced tumor growth in CCR5-deficient mice is associated with perturbed killing ability of Treg cells. Reduced tumor growth in CCR5-deficient mice is.
Effects of knockdown of ANRIL on NSCLC cell cycle and apoptosis in vitro. Effects of knockdown of ANRIL on NSCLC cell cycle and apoptosis in vitro. A,
A, chemical structures of PRIMA-1 and PRIMA-1Met.
In vitro invasion assays were done in the Chemicon invasion chamber containing extracellular matrix. In vitro invasion assays were done in the Chemicon.
Expression of versican G3 domain enhanced breast cancer cell mammosphere formation. Expression of versican G3 domain enhanced breast cancer cell mammosphere.
Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+
Flow cytometric analysis of T cell activation.
Anti-CD20 CAR mRNA enhances exPBNK in vitro cytolytic activity against CD20+ B-NHL cells and rituximab-resistant cells. exPBNK were electroporated in the.
Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis. Overexpression of miR-335, but not miR-29a, reduces in vitro carcinogenesis.
Β-Cryptoxanthin at a concentration of 10 μmol/L decreases proliferation in HCT116 cells after 6 and 8 days of treatment. β-Cryptoxanthin at a concentration.
Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.
PD-1 inhibition stimulates the proliferation and cytokine secretion of exhausted/senescent CD8+ T cells in vitro. PD-1 inhibition stimulates the proliferation.
IL-13Rα2 promotes cell survival and proliferation.
PTEN expression regulates autophagy in tumor cells, reducing T cell–mediated killing. PTEN expression regulates autophagy in tumor cells, reducing T cell–mediated.
BH3 profiling predicts venetoclax sensitivity in primary BPDCNs
Biological effects of BRAF silencing: growth curves of A375 (A) and ARO (B) cell lines in the absence or presence of doxycycline. Biological effects of.
Antitumor effects of celastrol in vitro and in vivo.
Bone marrow stroma partially protects multiple myeloma and AML cell lines from tipifarnib- and bortezomib-induced cell death. 8226/S myeloma cells were.
Time course of a G2-M arrest in response to 6-TG compared with IR and VP-16, showing that 6-TG induced a delayed G2-M arrest in MMR+ cells. Time course.
Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma cells. Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma.
FACS analyses of the inhibitory effect induced by mixed docetaxel, gefitinib, and cyclopamine on EGF plus SHHNp–stimulated PC3 cells. FACS analyses of.
Cytotoxic effect of BET inhibition in malignant B-cell lines and CLL patient-derived B cells is independent of survival signals. Cytotoxic effect of BET.
Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. LNCaP,
A, P causes G2-M arrest with apoptosis in asynchronous population of PC-3 when exposed to 1.5 and 5 μmol/L P for various time points. A, P
NKT cell recognition of CD1d1 molecules is inhibited by treatment with ascites. NKT cell recognition of CD1d1 molecules is inhibited by treatment with.
A24 induces apoptosis of MCL cells.
BCL6 represses NOTCH2 complex genes and NOTCH activity.
WP1066 induces caspase-dependent apoptosis.
Influence of ASGR2 expression on survival.
Increased apoptotic levels after combined treatment with vincristine (VCR) and imatinib. Increased apoptotic levels after combined treatment with vincristine.
Increased apoptotic levels after combined treatment with DXR and imatinib. Increased apoptotic levels after combined treatment with DXR and imatinib. A–D.
Induction of apoptosis by statins in NB4 cells and NB4 variant cell lines. Induction of apoptosis by statins in NB4 cells and NB4 variant cell lines. A,
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
VEGF165 stimulates migration of HMVECs
Ibrutinib decreases ofatumumab-mediated complement-dependent cytotoxicity. Ibrutinib decreases ofatumumab-mediated complement-dependent cytotoxicity. A,
Flavopiridol inhibits rhabdoid cell survival and induces cell cycle arrest and apoptosis. Flavopiridol inhibits rhabdoid cell survival and induces cell.
Measurements of the apoptotic response of CLL cells to radiation and the association with elevated genomic complexity. Measurements of the apoptotic response.
Sorafenib inhibits cell proliferation and induces apoptosis in HCC cells. Sorafenib inhibits cell proliferation and induces apoptosis in HCC cells. A,
Effect of BCAA on the progression of cell cycle, expression of p21CIP1, and induction of apoptosis in HepG2 cells in the presence and absence of visfatin.
Expression of TGFβ ligands in GBM
Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells. Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells.
B-cell development in young Pax5+/− mice.
ARQ 531 is cytotoxic to CLL cells, decreases NF-κB function, and inhibits migration. ARQ 531 is cytotoxic to CLL cells, decreases NF-κB function, and inhibits.
Expression of anti-versican shRNA decreased breast cancer cell mammosphere and colony formation. Expression of anti-versican shRNA decreased breast cancer.
miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.
Loss of NQO1 expression inhibits invasion of NSCLC
Overexpression of SUFU and GLI1 in the poor clinical outcome subgroup was confirmed by real-time PCR along with its association with disease progression.
WEE1 inhibition followed by TRAIL treatment results in apoptotic cell death in MB231 cells. WEE1 inhibition followed by TRAIL treatment results in apoptotic.
Effect of 6-SHO on mouse prostate cancer HMVP2 cells.
Presentation transcript:

Inhibition of stromal cell–induced survival of primary B-CLL cells by cyclopamine in vitro. Inhibition of stromal cell–induced survival of primary B-CLL cells by cyclopamine in vitro. Primary B-CLL cells were cultured in control medium or cocultured with OMA-AD stromal cells or OMA-AD cells with 5 μmol/L cyclopamine for 72 h. The proportion of B-CLL cells at different stages of apoptosis was determined by flow cytometry using the Annexin-PI assay. A to C. A representative culture of primary B-CLL cells on the OMA-AD stromal cell layer. D to F. Representative flow cytometric profile of B-CLL cells cultured in the presence of control medium or OMA-AD cells or OMA-AD cells with cyclopamine as determined by the Annexin-PI assay. There was a decrease in apoptotic B-CLL cells in the presence of coculture with OMA-AD stromal cells compared with controls, and this influence was reversed in B-CLL cells cocultured with OMA-AD cells and cyclopamine. G. Expression of Hh ligand in OMA-AD cells using mouse brain as positive control. H to K. Primary B-CLL cells were cultured in control medium or stromal-CM or stromal-CM with 5 μmol/L cyclopamine for 24 h, and GLI1 expression was determined by real-time PCR. The proportion of B-CLL cells at different stages of apoptosis was determined after 72 h by flow cytometry using the Annexin-PI assay. There was a significantly increased GLI1 expression (fold change) and decreased apoptotic cell population in the presence of stromal-CM compared with control. The effect was reversed by cyclopamine. Results are obtained from B-CLL cells of three different patients. Ganapati V. Hegde et al. Mol Cancer Res 2008;6:1928-1936 ©2008 by American Association for Cancer Research